GFR IN HYPERTENSIVE AFRICAN AMERICANS
753
causation of end-stage renal disease (ESRD). Trans Am Soc
Artif Intern Organs 23:28-33, 1977
7. McClellan W, Tuttle E, Issa A: Racial differences in
the incidence of hypertensive end-stage renal disease are not
entirely explained by differences in the prevalence of hyper-
tension. Am J Kidney Dis 12:285-290, 1988
8. Rostand SG, Kirk KA, Rutsky EA, Pate EA: Racial
differences in the incidence of treatment for end-stage renal
disease. N Engl J Med 306:1276-1279, 1982
9. Whittle JC, Whelton PK, Seidler AJ, Klag MJ: Does
racial variation in risk factors explain black-white differ-
ences in the incidence of hypertensive end-stage renal dis-
ease? Arch Intern Med 151:1359-1364, 1991
10. Walker GW, Neaton JD, Cutler JA, Neuwirth R,
Cohen JD: Renal function change in hypertensive members
of the Multiple Risk Factor Intervention Trial. JAMA 268:
3085-3091, 1992
11. Wright JT Jr, Kirk KA, Kusek JW, Toto R, Lee JY,
Agodoa LY, Randall OS, Glassock R, for the AASK Pilot
Study Investigators: Design and baseline characteristics of
participants in the African-American Study of Kidney Dis-
ease and Hypertension (AASK) Pilot Study. Control Clin
Trials 17:S3-S54, 1996 (suppl 1)
12. Fogo A, Breyer JA, Smith MC, Cleveland WH,
Agodoa L, Kirk KA, Glassock R, and the AASK Pilot Study
Investigators. Accuracy of the diagnosis of hypertensive
nephrosclerosis in African Americans: A report from the
African-American Study of Kidney Disease (AASK) Trial.
Kidney Int 51:244-252, 1997
13. Perrone R, Beck GJ, Skibinski CI, Royal H, Lawlor
M, Hunsicker L, for the Modification of Diet in Renal
Disease Study Group: Utility of radioisotopic filtration mark-
ers in chronic renal insufficiency: Simultaneous comparison
of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA and inulin.
Am J Kidney Dis 16:224-235, 1990
Western Reserve University, Cleveland, OH:
Jackson Wright, MD, PhD; Emory University,
Decatur, GA: Janice Lea, MD; Harbor-Univer-
sity of California at Los Angeles Medical Center,
Torrance, CA: Joel Kopple, MD; Howard Univer-
sity, Washington, DC: Otelio S. Randall, MD;
Johns Hopkins University, Baltimore, MD: Law-
rence J. Appel, MD, MPH; Martin Luther King–
Drew Medical College, Los Angeles, CA: Keith
Norris, MD; Medical University of South Caro-
lina, Charleston, SC: DeAnna Cheek, MD; Me-
harry Medical College, Nashville, TN: Mar-
quetta Faulkner, MD; Harlem Hospital Center,
New York, NY: Velvie Pogue, MD; Morehouse
School of Medicine, Atlanta, GA: William Cleve-
land, MD; Mount Sinai School of Medicine,
New York, NY: Robert A. Phillips, MD, PhD;
Ohio State University, Columbus, OH: Lee He-
bert, MD; Rush Presbyterian/St Luke’s Medical
Center, Chicago, IL: George L. Bakris, MD;
University of Alabama, Birmingham, AL: Ste-
phen G. Rostand, MD; University of Florida,
Gainesville, FL: C. Craig Tisher, MD; University
of Miami, Miami, FL: Jacques J. Bourgoignie,
MD; University of Michigan, Ann Arbor, MI:
Kenneth Jamerson, MD; University of Southern
California, Los Angeles, CA: Shaul G. Massry,
MD; The University of Texas Southwestern Medi-
cal Center, Dallas, TX: John Middleton, MD;
Vanderbilt University, Nashville, TN: Julia Lewis,
MD; Data Coordinating Center: Cleveland Clinic
Foundation, Cleveland, OH: Jennifer Gassman,
PhD, Tom Greene, PhD.
14. Levey AS, Greene T, Schluchter MD, Cleary PA, Te-
schan PE, Lorenz RA, Molitch ME, Mitch WE, Siebert C, Hall
PM, Steffes MW, and the Modification of Diet in Renal Disease
Study Group: Glomerular filtration rate measurements in clini-
cal trials. J Am Soc Nephrol 4:1159-1171, 1993
15. Toto RD, Kirk KA, Coresh J, Jones C, Appel L,
Wright J, Campese V, and the AASK Pilot Study Investiga-
tors: Evaluation of serum creatinine for estimating glomeru-
lar filtration rate in African Americans with hypertensive
nephrosclerosis: Results from the African-American Study
of Kidney Disease and Hypertension (AASK) Pilot Study.
J Am Soc Nephrol 8:279-287, 1997
16. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS,
Herman WH, Coresh J, Salive M, Jones CP, Agadoa LY:
Serum creatinine levels in the US population: Third National
Health and Nutrition Examination Survey. Am J Kidney Dis
32:992-999, 1998
REFERENCES
1. Levey AS: Nephrology forum: Measurement of renal
function in chronic renal disease. Kidney Int 38:167-184, 1990
2. Cockcroft DW, Gault MH: Prediction of creatinine
clearance from serum creatinine. Nephron 16:31-41, 1976
3. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N,
Roth D, and the Modification of Diet in Renal Disease Study
Group: A more accurate method to estimate glomerular
filtration rate from serum creatinine: A new prediction equa-
tion. Ann Intern Med 130:461-470, 1999
4. US Renal Data System: USRDS 1999 Annual Data
Report. The National Institutes of Health, National Institute
of Diabetes and Digestive and Kidney Diseases, Bethesda,
MD, 1999
17. Coggins CH, Breyer JA, Caggiula AW, Castaldo LS,
Klahr S, Wang SR: Differences between women and men
with chronic renal disease. Nephrol Dial Transplant 13:1430-
1437, 1998
5. Blythe WB, Maddux FW: Hypertension as a causative
diagnosis of patients entering end-stage renal disease pro-
grams in the United States from 1986-1980. Am J Kidney
Dis 18:33-37, 1991
18. Whelton P, Lee J, Kopple J, Faulkner M, Charleston
J, for the AASK Pilot Investigators: Recruitment in the
African-American Study of Kidney Disease and Hyperten-
sion (AASK) Pilot Study. J Am Soc Nephrol 5:570A, 1994
(abstr)
6. Easterling RE: Racial factors in the incidence and